Park Soonbum, Lee Sanghoon, Park Eun-Jung, Kang MinJi, So Insuk, Jeon Ju-Hong, Chun Jung Nyeo
Department of Physiology and Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, South Korea.
Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT, 84112-5650, USA.
Biochem Biophys Res Commun. 2017 Jan 29;483(1):129-134. doi: 10.1016/j.bbrc.2016.12.179. Epub 2016 Dec 27.
Aberrant transforming growth factor β1 (TGFβ1) signaling plays a crucial role in the pathogenesis of vascular fibrosis. On the other hand, deregulated transient receptor potential canonical 6 (TRPC6) channel expression shows impaired vascular physiology and wound healing. However, it has little been known about the functional association between TGFβ1 and TRPC6 in vascular smooth muscle cells (VSMCs). In this study, we analyzed the microarray data obtained from TGFβ1-treated A7r5 VSMCs. We found that TGFβ1 specifically elevates the expression level of TRPC6 mainly through Smad-dependent canonical pathway. The siRNA against TRPC6 abolished TGFβ1-induced molecular and cellular phenotype changes, including myosin light chain phosphorylation, actin stress fiber formation, and cell migration. These results demonstrate that TRPC6 is an important component of TGFβ1 signaling pathway in VSMCs. Therefore, our findings provide a basis for future investigation aimed at developing novel therapeutic strategies for treatment of vascular fibrosis.
异常的转化生长因子β1(TGFβ1)信号传导在血管纤维化的发病机制中起关键作用。另一方面,瞬时受体电位经典型6(TRPC6)通道表达失调显示血管生理功能受损和伤口愈合不良。然而,关于TGFβ1与血管平滑肌细胞(VSMC)中TRPC6的功能关联知之甚少。在本研究中,我们分析了从TGFβ1处理的A7r5 VSMC获得的微阵列数据。我们发现TGFβ1主要通过Smad依赖的经典途径特异性提高TRPC6的表达水平。针对TRPC6的小干扰RNA消除了TGFβ1诱导的分子和细胞表型变化,包括肌球蛋白轻链磷酸化、肌动蛋白应力纤维形成和细胞迁移。这些结果表明TRPC6是VSMC中TGFβ1信号通路的重要组成部分。因此,我们的研究结果为未来旨在开发治疗血管纤维化新治疗策略的研究提供了基础。